We are live on
!
Find out more
Royce & Associates Portfolio holdings
AUM
$12.4B
Turnover
20.64%
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter
Est. Return
+2.79%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.6B
AUM Growth
-$258M
(-0.76%)
Cap. Flow
-$892M
Cap. Flow
% of AUM
-2.66%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
1,511
New
98
Increased
472
Reduced
496
Closed
89
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nu Skin
NUS
|
+$123M |
| 2 |
Dana Inc
DAN
|
+$61.6M |
| 3 |
BRCD
Brocade Communications Systems, Inc. NEW
BRCD
|
+$55.3M |
| 4 |
Civeo
CVEO
|
+$37.3M |
| 5 |
ePlus
PLUS
|
+$30M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zebra Technologies
ZBRA
|
+$107M |
| 2 |
Helmerich & Payne
HP
|
+$90.6M |
| 3 |
Oil States International
OIS
|
+$59.7M |
| 4 |
Reliance Steel & Aluminium
RS
|
+$59.4M |
| 5 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 24.45% |
| 2 | Technology | 18.1% |
| 3 | Consumer Discretionary | 14.79% |
| 4 | Financials | 9.92% |
| 5 | Materials | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1051
Medifast
MED
$135M
| $1.82M | 0.01% |
60,000
-108,000
| -64% | -$3.37M |
2013 Q2
4 quarters
|
|
1052
Moog Inc Class A
MOG.A
$11.6B
| $1.82M | 0.01% |
25,000
| – | – |
2013 Q2
4 quarters
|
|
|
CKP
1053
DELISTED
CHECKPOINT SYSTEMS INC
CKP
| $1.82M | 0.01% |
+130,000
| New | +$1.7M |
2014 Q2
0 quarters
|
|
1054
Employers Holdings
EIG
$906M
| $1.82M | 0.01% |
85,721
+821
| +1% | +$17.2K |
2013 Q2
4 quarters
|
|
1055
DELISTED
Cross Country Healthcare
CCRN
| $1.81M | 0.01% |
277,900
| – | – |
2013 Q2
4 quarters
|
|
1056
Ardmore Shipping
ASC
$775M
| $1.8M | 0.01% |
130,075
-1,600
| -1% | -$21.6K |
2013 Q3
3 quarters
|
|
|
BSTG
1057
DELISTED
Biostage, Inc. Common Stock
BSTG
| $1.8M | 0.01% |
172,074
-19,700
| -10% | -$168K |
2013 Q4
2 quarters
|
|
1058
Assurant
AIZ
$13.9B
| $1.8M | 0.01% |
27,412
+3,053
| +13% | +$204K |
2013 Q2
4 quarters
|
|
1059
DELISTED
ProAssurance
PRA
| $1.79M | 0.01% |
40,400
-523,298
| -93% | -$23.4M |
2013 Q2
4 quarters
|
|
1060
DELISTED
Profire Energy, Inc
PFIE
| $1.77M | 0.01% |
+391,912
| New | +$1.67M |
2014 Q2
0 quarters
|
|
1061
Equifax
EFX
$18.9B
| $1.75M | 0.01% |
24,150
| – | – |
2013 Q2
4 quarters
|
|
1062
Vaalco Energy
EGY
$632M
| $1.74M | 0.01% |
240,000
-82,000
| -25% | -$622K |
2013 Q2
4 quarters
|
|
1063
Neonode
NEON
$13.4M
| $1.73M | 0.01% |
55,386
+27,500
| +99% | +$1.19M |
2013 Q3
3 quarters
|
|
|
NVCN
1064
DELISTED
Neovasc Inc.
NVCN
| $1.71M | 0.01% |
+11
| New | +$1.75M |
2014 Q2
0 quarters
|
|
|
MDSO
1065
DELISTED
Medidata Solutions, Inc.
MDSO
| $1.71M | 0.01% |
40,000
| – | – |
2013 Q2
4 quarters
|
|
1066
Skyworks Solutions
SWKS
$18.6B
| $1.7M | 0.01% |
36,200
-19,300
| -35% | -$813K |
2013 Q3
3 quarters
|
|
|
ENVI
1067
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
| $1.7M | 0.01% |
708,000
| – | – |
2013 Q2
4 quarters
|
|
1068
Western Copper and Gold
WRN
$414M
| $1.68M | 0.01% |
2,182,500
-30,000
| -1% | -$26.3K |
2013 Q2
4 quarters
|
|
|
JOY
1069
DELISTED
Joy Global Inc
JOY
| $1.66M | ﹤0.01% |
27,000
+4,300
| +19% | +$259K |
2013 Q3
3 quarters
|
|
|
SNAK
1070
DELISTED
Inventure Foods, Inc.
SNAK
| $1.66M | ﹤0.01% |
147,000
-8,000
| -5% | -$101K |
2013 Q2
4 quarters
|
|
|
ETRM
1071
DELISTED
EnteroMedics Inc.
ETRM
| $1.65M | ﹤0.01% |
1,010
-214
| -17% | -$400K |
2013 Q2
4 quarters
|
|
1072
DELISTED
BioAmber Inc.
BIOA
| $1.64M | ﹤0.01% |
164,979
| – | – |
2013 Q4
2 quarters
|
|
|
CBI
1073
DELISTED
Chicago Bridge & Iron Nv
CBI
| $1.64M | ﹤0.01% |
24,056
-944
| -4% | -$75.1K |
2013 Q2
4 quarters
|
|
1074
Trimble
TRMB
$14.2B
| $1.63M | ﹤0.01% |
44,200
| – | – |
2013 Q2
4 quarters
|
|
|
THST
1075
DELISTED
Truett-Hurst, Inc. Class A Common Stock
THST
| $1.63M | ﹤0.01% |
320,000
-13,500
| -4% | -$68.2K |
2013 Q2
4 quarters
|
|
Similar funds
Royce & Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Royce & Associates held 1,511 positions worth $33.6B, down 0.76% from $33.9B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Royce & Associates's Q2 2014 filing shows 98 new, 472 increased, 496 reduced and 89 closed positions. Its largest new stake was Civeo: 124,691 shares worth $37.5M. The largest sale was Zebra Technologies, an estimated $107M.
By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
- Royce & Associates's largest Q2 2014 buy was Civeo: 124,691 shares worth $37.5M.
- Royce & Associates added most to Nu Skin in Q2 2014, an estimated $123M increase.
- Royce & Associates's biggest Q2 2014 reduction was Zebra Technologies, cutting an estimated $107M.
- Royce & Associates fully exited Entegris in Q2 2014, selling an estimated $35.5M.
- Royce & Associates's ten largest holdings make up 9.6% of its $33.6B portfolio in Q2 2014.
- Royce & Associates opened 98 new positions and closed 89 in Q2 2014.
- Royce & Associates's portfolio value fell 0.76% quarter-over-quarter to $33.6B.
Based on Royce & Associates's 13F filing for Q2 2014, filed 11 Aug 2014.